IN8BIO, Inc. SEC filings INAB
IN8BIO, Inc. has 410 filings in SEC EDGAR's recent list, going back to May 22, 2018. Its latest annual report, Form ARS, was filed on Mar 26, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 6, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 6, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| S-8 | Employee stock plan registration | Aug 7, 2026 | — |
| 424B5 | Prospectus supplement | Jun 1, 2026 | — |
| S-3/A | Filing | May 18, 2026 | — |
| S-8 POS | Filing | May 7, 2026 | — |
| S-8 POS | Filing | May 7, 2026 | — |
| S-8 POS | Filing | May 7, 2026 | — |
| S-8 POS | Filing | May 7, 2026 | — |
| S-8 POS | Filing | May 7, 2026 | — |
| S-8 | Employee stock plan registration | May 7, 2026 | — |
| 424B3 | Prospectus | Jan 30, 2026 | — |
| S-3 | Shelf registration | Jan 20, 2026 | — |
| S-3 | Shelf registration | Nov 7, 2025 | — |
| S-8 | Employee stock plan registration | Mar 13, 2025 | — |
| 424B3 | Prospectus | Nov 12, 2024 | — |
| S-3 | Shelf registration | Nov 4, 2024 | — |
| 424B5 | Prospectus supplement | Aug 12, 2024 | — |
| 424B5 | Prospectus supplement | May 7, 2024 | — |
| S-8 | Employee stock plan registration | Jan 19, 2024 | — |
| 424B3 | Prospectus | Jan 18, 2024 | — |
| S-3 | Shelf registration | Jan 12, 2024 | — |
| S-8 POS | Filing | Aug 18, 2023 | — |
| S-8 POS | Filing | Aug 18, 2023 | — |
| S-8 | Employee stock plan registration | Aug 18, 2023 | — |
| 424B5 | Prospectus supplement | Jul 31, 2023 | — |
| 424B5 | Prospectus supplement | Jul 14, 2023 | — |
| 424B5 | Prospectus supplement | Apr 27, 2023 | — |
| 424B5 | Prospectus supplement | Apr 26, 2023 | — |
| S-3 | Shelf registration | Nov 10, 2022 | — |
| 424B4 | Prospectus | Aug 15, 2022 | — |
| S-1/A | Amended registration statement | Aug 9, 2022 | — |
| S-1 | Registration statement | Aug 8, 2022 | — |
| S-8 | Employee stock plan registration | May 12, 2022 | — |
| S-8 | Employee stock plan registration | Sep 10, 2021 | — |
| 424B4 | Prospectus | Jul 30, 2021 | — |
| S-1/A | Amended registration statement | Jul 22, 2021 | — |
| S-1/A | Amended registration statement | Jul 20, 2021 | — |
| S-1/A | Amended registration statement | May 7, 2021 | — |
| S-1/A | Amended registration statement | Mar 31, 2021 | — |
| S-1/A | Amended registration statement | Nov 5, 2020 | — |
| S-1 | Registration statement | Oct 16, 2020 | — |
Showing 40 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- INAB (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- New York, NY
- SEC filer status
- Non-accelerated filer, Smaller reporting company, Emerging growth company
- SEC CIK
- 1740279
- Former names
- Incysus Therapeutics, Inc. (until Sep 20, 2018)
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.